Children with SARS-CoV-2 infection have been consistently described with
milder clinical outcomes compared to adults. However, data pertaining to
the clinical evolution of SARS-CoV-2 infection in children with cancer
remain scarce. In this descriptive cohort study, we report the clinical
characteristics and outcomes of 31 pediatric oncology patients with
SARS-CoV-2 infection in the province of Quebec, Canada. Most patients
were asymptomatic or had mild symptoms, with only 2 COVID-19-related
hospitalizations and no COVID-19-related deaths. The favorable outcomes
in our cohort may be explained by Quebec's universal access to health
care and regionalization of pediatric oncology care in tertiary centers
exclusively.